1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENMAB - ADR
Genmab - ADR XNAS: GMAB
Strong Performer, Getting Expensive
25.84 0.97 (3.90%)
49.88% Gain from 52W Low
1.8M
XNAS Volume

XNAS 02 Sep, 2025 3:47 PM (EDT)

Watchlist

Portfolio

Alert

Share

Detailed Stock Analysis for Genmab - ADR with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to Pro or ProPlus
Subscribe Sign in